Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CIMP-positive glioma is associated with better prognosis: A systematic analysis.

Medicine - 30 Sept 2022

Xu Yingying, Xiao Huashi, Hu Wenqing, Shen He-Chun, Liu Wanjun, Tan Siyuan, Ren Chuanli, Zhang Xiaomin, Yang Xishuai, Yu Guo, Yang Ting, Yu Duonan, Zong Liang

Abstract excerpt

BACKGROUND: CpG island methylator phenotype (CIMP) was closely related to the degree of pathological differentiation of tumors, and it's an important determinant of glioma pathogenicity. However, the molecular and pathological features of CIMP-positive glioma have not been fully elucidated. In addition, CIMP have been reported to be a useful prognostic marker in several human cancers, yet its prognostic value in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to CpG Islands

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Methylation

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Oligodendroglioma

Share to Phenotype

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 36181110
DOI: 10.1097/MD.0000000000030635
PMCID: PMC9524892

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CIMP-positive glioma is associated with better prognosis: A systematic analysis.PMID 36181110Read ↗

Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical ImplicationsSemantic proximity Read ↗

Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications.Semantic proximity Read ↗

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.Semantic proximity Read ↗

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype.Semantic proximity Read ↗

The Cancer Genome Atlas expression profiles of low-grade gliomas.Semantic proximity Read ↗

The CpG island methylator phenotype: what's in a name?Semantic proximity Read ↗

IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.Semantic proximity Read ↗

Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis.Semantic proximity Read ↗

Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risksSemantic proximity Read ↗

Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patientsSemantic proximity Read ↗

Diagnostic and prognostic markers in gliomas - an update.Semantic proximity Read ↗

A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.